These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 17452063)
1. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. Ortar G; Cascio MG; Moriello AS; Camalli M; Morera E; Nalli M; Di Marzo V Eur J Med Chem; 2008 Jan; 43(1):62-72. PubMed ID: 17452063 [TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms. Maione S; Morera E; Marabese I; Ligresti A; Luongo L; Ortar G; Di Marzo V Br J Pharmacol; 2008 Nov; 155(5):775-82. PubMed ID: 18660824 [TBL] [Abstract][Full Text] [Related]
3. Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? Fowler CJ; Ghafouri N Pharmacol Res; 2008 Jul; 58(1):72-6. PubMed ID: 18675915 [TBL] [Abstract][Full Text] [Related]
4. The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases. Alexander JP; Cravatt BF J Am Chem Soc; 2006 Aug; 128(30):9699-704. PubMed ID: 16866524 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384 [TBL] [Abstract][Full Text] [Related]
6. New tetrazole-based selective anandamide uptake inhibitors. Ortar G; Schiano Moriello A; Cascio MG; De Petrocellis L; Ligresti A; Morera E; Nalli M; Di Marzo V Bioorg Med Chem Lett; 2008 May; 18(9):2820-4. PubMed ID: 18424134 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin. Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826 [TBL] [Abstract][Full Text] [Related]
8. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide. Fowler CJ Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648 [TBL] [Abstract][Full Text] [Related]
9. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. De Lago E; Gustafsson SB; Fernández-Ruiz J; Nilsson J; Jacobsson SO; Fowler CJ J Neurochem; 2006 Oct; 99(2):677-88. PubMed ID: 16899063 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. Vandevoorde S; Fowler CJ Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. Cisneros JA; Vandevoorde S; Ortega-Gutiérrez S; Paris C; Fowler CJ; López-Rodríguez ML J Med Chem; 2007 Oct; 50(20):5012-23. PubMed ID: 17764163 [TBL] [Abstract][Full Text] [Related]
12. FAAH and anandamide: is 2-AG really the odd one out? Di Marzo V; Maccarrone M Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720 [TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181 [TBL] [Abstract][Full Text] [Related]
14. Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis. Pulgar VM; Yamaleyeva LM; Varagic J; McGee CM; Bader M; Dechend R; Howlett AC; Brosnihan KB Hypertension; 2014 Sep; 64(3):619-25. PubMed ID: 24935942 [TBL] [Abstract][Full Text] [Related]
16. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Williams J; Wood J; Pandarinathan L; Karanian DA; Bahr BA; Vouros P; Makriyannis A Anal Chem; 2007 Aug; 79(15):5582-93. PubMed ID: 17600384 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. Thors L; Eriksson J; Fowler CJ Br J Pharmacol; 2007 Nov; 152(5):744-50. PubMed ID: 17676056 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073 [TBL] [Abstract][Full Text] [Related]
19. Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro. Vandevoorde S; Jonsson KO; Labar G; Persson E; Lambert DM; Fowler CJ Br J Pharmacol; 2007 Jan; 150(2):186-91. PubMed ID: 17143303 [TBL] [Abstract][Full Text] [Related]
20. Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism. Ortar G; Bisogno T; Ligresti A; Morera E; Nalli M; Di Marzo V J Med Chem; 2008 Nov; 51(21):6970-9. PubMed ID: 18831576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]